Search results Search results Search results

Search results

Topas Therapeutics Announces Positive Topline Results from Phase 2a Trial Evaluating TPM502 in Patients with Celiac Disease

Press release

Korantin Hénaff Le Gall

Team member

Brouwerij Martens acquires United Dutch Breweries with a purpose of further joint global expansion

Press release

Koen Bouckaert*

Team member

Luc Missorten°

Team member

Gimv participates in a $92M Series A financing round at Kivu Bioscience to advance next-gen antibody-drug conjugates

Press release

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

Press release

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

Press release

Team member

Gimv acquires Groupe Tibbloc, leader in rental of ready-to-use temporary energy solutions and related services, from Ciclad

Press release